Albert Dobi
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- Cancer, Lipids, and Metabolism
- MicroRNA in disease regulation
-
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
Papers in
-
- Prostate Cancer Treatment and Research 37
- Prostate Cancer Diagnosis and Treatment 11
-
- Ubiquitin and proteasome pathways 5
- Molecular Biology Techniques and Applications 4
- S100 Proteins and Annexins 3
- Co-authors
- Shiv Srivastava (52 shared papers)György Petrovics (26 shared papers)Isabell A. Sesterhenn (27 shared papers)David G. McLeod (18 shared papers)Lakshmi Ravindranath (16 shared papers)Yongmei Chen (15 shared papers)Bungo Furusato (10 shared papers)Jennifer Cullen (10 shared papers)
- Journals
- Cancer Research (8 papers)The Journal of Urology (7 papers)Prostate Cancer and Prostatic Diseases (5 papers)Oncogene (2 papers)Oncotarget (2 papers)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Albert Dobi
62 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 78
- Cancer Research 359
- Pulmonary and Respiratory Medicine 549
- Molecular Biology 622
- Molecular Medicine 35
- Oncology 143
Countries citing papers authored by Albert Dobi
This map shows the geographic impact of Albert Dobi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albert Dobi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albert Dobi more than expected).
Fields of papers citing papers by Albert Dobi
This network shows the impact of papers produced by Albert Dobi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albert Dobi. The network helps show where Albert Dobi may publish in the future.
Co-authors
The 25 scholars most cited alongside Albert Dobi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 150 | |
| 2 | 2007 | 118 | |
| 3 | 2006 | 67 | |
| 4 | 2012 | 60 | |
| 5 | 2011 | 56 | |
| 6 | 2007 | 54 | |
| 7 | 2018 | 47 | |
| 8 | 2007 | 47 | |
| 9 | 2013 | 36 | |
| 10 | 2008 | 36 | |
| 11 | 2017 | 34 | |
| 12 | 2020 | 33 | |
| 13 | 2015 | 30 | |
| 14 | 2019 | 28 | |
| 15 | 2010 | 27 | |
| 16 | 2007 | 26 | |
| 17 | 2014 | 23 | |
| 18 | 2015 | 23 | |
| 19 | 2007 | 21 | |
| 20 | 2016 | 21 |
About Albert Dobi
Albert Dobi is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research, Endocrinology, Diabetes and Metabolism and Genetics, having authored 63 papers that have together received 1.2k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (37 papers), Prostate Cancer Diagnosis and Treatment (11 papers), Cancer, Lipids, and Metabolism (8 papers), Ubiquitin and proteasome pathways (5 papers), Molecular Biology Techniques and Applications (4 papers), Estrogen and related hormone effects (4 papers), Cancer, Hypoxia, and Metabolism (4 papers) and S100 Proteins and Annexins (3 papers). The work is most often cited by research in Cancer Research (359 citations), Pulmonary and Respiratory Medicine (549 citations), Molecular Biology (622 citations), Molecular Medicine (35 citations) and Oncology (143 citations). Albert Dobi has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Shiv Srivastava, György Petrovics, Isabell A. Sesterhenn, David G. McLeod, Lakshmi Ravindranath, Yongmei Chen, Bungo Furusato, Jennifer Cullen, Syed Shaheduzzaman and Denise Young. Their work appears in journals such as Cancer Research, The Journal of Urology, Prostate Cancer and Prostatic Diseases, Oncogene and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.